Factors in Duration of Anxiolytic, Sedative, and Hypnotic Drug Use in the Elderly

Canadian Journal of Nursing Research

Volumn 35, Issue 4, 2003, Pages 126-149

  Voyer, Philippe ^a,b   McCubbin, Michael ^a,c   Préville, Michel ^d   Boyer, Richard ^e,f  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Res Grp Social Intgn Org E   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

^e CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Addiction; Anxiolytic; Benzodiazepine; Elderly; Hypnotic; Long term use; Psychotropic; Sedative; Short term use; Tranquillizer; Withdrawal

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; HYPNOTIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; TRANQUILIZER; HYPNOTIC SEDATIVE AGENT;

AGED; ARTICLE; CANADA; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; DRUG USE; FEMALE; HEALTH PROGRAM; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPOTHESIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NURSE; PREVALENCE; SEX DIFFERENCE; WITHDRAWAL SYNDROME; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; COMMUNITY HEALTH NURSING; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; EPIDEMIOLOGY; GERIATRIC ASSESSMENT; METHODOLOGY; NURSE ATTITUDE; PRESCRIPTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; SOCIOECONOMICS; STANDARD; STATISTICAL MODEL; STATISTICS; TIME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTI-ANXIETY AGENTS; ATTITUDE TO HEALTH; COMMUNITY HEALTH NURSING; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; GERIATRIC ASSESSMENT; HEALTH CARE SURVEYS; HUMANS; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MENTAL HEALTH; NURSE'S ROLE; PRESCRIPTIONS, DRUG; QUEBEC; QUESTIONNAIRES; RESEARCH DESIGN; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 1442309915     PISSN: 08445621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. Addiction Science Network (2003, March). A primer on drug addiction. Available on the World Wide Web: www.addictionscience.net
2. Allard, J., Allaire, D., Leclerc, G., & Langlois, S.-P. (1995).The influence of family and social relationships on the consumption of psychotropic drugs by the elderly. Archives of Gerontology and Geriatrics, 20, 193-204.
3. Allen, R. M. (1986).Tranquilizers and sedative/hypnotics: Appropriate use in the elderly. Geriatrics, 47(5), 57-88.
4. Ankri, J., Collin, J., Pérodeau, G., & Beaufils, B. (2002). Médicaments psychotropes et sujets âgés: Une problématique commune France-Québec? (synthèse de la littérature). Sciences sociales et santé, 20(1), 34-62.
5. Antonijoan, R. M., Barbanoj, M. J., Torrent, J., & Jane, F. (1990). Evaluation of psychotropic drug consumption related to psychological distress in the elderly: Hospitalized vs. nonhospitalized. Neuropsychobiology, 23, 25-30.
6. Arinen, S., Häkkinen, U., Klaukka, T., Klavus, J., Lehtonen, R., & Aro, S. (1998). Health and the use of health services in Finland: Main findings of the Finnish Health Care Survey 1995/96 and changes from 1987. Helsinki: SVT Health.
7. Audet, N., Lemieux, M., & Cardin, J. F. (2001). Enquête sociale et de santé 1998. Cahier technique et méthodologique: Définition et composition des indices, Vol. 2. Montreal: Institut de la statistique du Québec.
8. Berg, S., & Dellasega, C. (1996).The use of psychoactive medications and cognitive function in older adults. Journal of Aging and Health, 8(1), 136-149.
9. Besley, D., Kuh, E., & Welsch, R. (1980). Regression diagnostics: Identifying influential data and sources of collinearity. New York: John Wiley.
10. Blazer, D., Hybels, C., Simonsick, E. M., & Hanlon, J. T. (2000a). Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. American Journal of Psychiatry, 157, 1089-1094.
11. Blazer, D., Hybels, C., Simonsick, E. M., & Hanlon, J. T. (2000b). Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: A racial comparison. Journal of the American Geriatrics Society, 48, 1073-1079.
12. Borg, S., & Larsson, S. (2001). Epilogue: Drawing together the threads and perspectives on the long-term use of psychotropics. Substance Use and Misuse, 36, 1357-1367.
13. Caces, M. F., Harford, T. C., & Aitken, S. S. (1998). Prescription and non-prescription drug use: A longitudinal study. Journal of Substance Abuse, 10(2), 115-126.
14. Cafferata, G. L., Kasper, J., & Bernstein, A. (1983). Family roles, structure, and stressors in relation to sex differences in obtaining psychotropic drugs. Journal of Health and Social Behavior, 24, 132-143.
15. Chambers, C. D., & White, O. Z. (1980). Characteristics of high-frequency consumers of prescription psychoactive drugs. Chemical Dependencies: Behavioral and Biomedical Issues, 4(1), 33-46.
16. Chen, Y.-F., Dewey, M. E., Avery, A. J., & the Analysis Group of the MRCCFA Study. (2001). Self-reported medication use for older people in England and Wales. Journal of Clinical Pharmacy and Therapeutics, 26, 129-140.
17. Clinthorne, J. K., Cisin, I. H., Baiter, M. B., Mellinger, G. D., & Uhlenhuth, E. H. (1986). Changes in popular attitudes and beliefs about tranquillizers. Archives of General Psychiatry, 43, 527-532.
18. Cohen, D., & Collin, J. (1997). Les toxicomanies en lien avec les médicaments psychotropes chez les personnes âgées, les femmes et les enfants: Recension et analyse des écrits. Quebec: Ministère de la Santé et des Services sociaux, Groupe de travail sur la prévention des toxicomanies.
19. Cohen, D., McCubbin, M., Collin, J., & Pérodeau, G. (2001). Medications as social phenomena. Health: An Interdisciplinary Journal for the Study of Health, Illness, and Medicine, 5, 441-469.
20. Collin, J. (2001). Médicaments psychotropes et personnes âgées: Une socialisation de la consommation. Revue québécoise de psychologie, 22(2), 75-98.
21. Collin, J., Damestoy, N., & Lalande, R. (1999). La construction d'une rationnalité: Les médecins face à la prescription de psychotropes aux personnes âgées. Sciences sociale et santé, 17(2), 31-50.
22. Colvez, A., Carrière, I., Castex, A., & Favier, F. (2002). Recherche d'une typologie des consommations médicamenteuses des personnes âgées vivant à domicile. In search of a typology of drugs used by the aged living in the community. Revue d'épidemiologie et santé publique, 50, 121-133.
23. Cooperstock, R. (1971). Sex differences in the use of mood modifying drugs: An explanatory model. Journal of Health and Social Behavior, 12, 228-244.
24. Cooperstock, R., & Parnell, P. (1982). Research on psychotropic drug use: A review of findings and methods. Social Science and Medicine, 16, 1179-1196.
25. Damestoy, N., Collin, J., & Lalande, R. (1999). Prescribing psychotropic medication for elderly patients: Some physicians' perspectives. Canadian Medical Association Journal, 161(2), 143-145.
26. Daveluy, C., Pica, L., Audet, R., Courtemanche, R., Lapointe, E, Côté, L., & Baume, J. (2001). Enquête sociale et de santé 1998. Cahier technique et méthodologique: Documentation générale, Vol. 1. Montreal: Institut de la statistique du Québec.
27. Dealberto, M. J., McAvay, G. J., Seeman, T., & Berkman, L. (1997). Psychotropic drug use and cognitive decline among older men and women. International Journal of Geriatric Psychiatry, 12, 567-574.
28. Dealberto, M. J., Seeman, T., McAvay, G. J., & Berkman, L. (1997). Factors related to current and subsequent psychotropic drug use in an elderly cohort. Journal of Clinical Epidemiology, 50, 357-364.
29. Ebly, E. M., Hogan, D. B., & Fung,T. S. (1997). Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. Journal of Clinical Epidemiology, 50, 857-863.
30. Ettore, E., Klaukka, T., & Riska, E. (1994). Psychotropic drugs: Long-term use, dependency and gender factor. Social Science and Medicine, 39, 1667-1673.
31. Ettore, E., & Riska, E. (2001). Long-term, users of psychotropic drugs: Embodying masculinized stress and feminized nerves. Substance Use and Misuse, 35, 1187-1211.
32. Fernandez, L., & Cassagne-Pinel, C. (2001). Addiction aux benzodiazepines et symptomatologie anxieuse et dépressive chez les sujets âgés. Encephale, 27, 459-474.
33. Finlayson, F. E. (1995). Misuse of prescription drugs. International Journal of the Addictions, 30, 1871-1901.
34. Fourrier, A., Letenneur, L., Dartigues, J. F., Moore, N., & Bégaud, B. (2001). Benzodiazepine use in an elderly community-dwelling population: Characteristics of users and factors associated with subsequent use. European Journal of Clinical Pharmacology, 57, 419-425.
35. Gillespie, L. D., Gillespie, W. J., Robertson, M. C., Lamb, S. E., Cumming, R. G., & Rowe, B. H. (2001). Interventions for preventing falls in the elderly. Oxford: Cochrane Library.
36. Glazer, G. B., & Zawadski, R. T. (1981). Use of psychotropic drugs among the aged revisited. Journal of Psychoactive Drugs, 13, 195-198.
37. Gleason, P. P., Schultz, R., Smith, N. L., Newsom, J. T., Kroboth, F. J., & Psaty, B. M. (1998). Correlates and prevalence of benzodiazepine use in community-dwelling elders. Journal of General Internal Medicine, 13, 243-250.
38. Golstein, M. S., Siegel, J. M., & Boyer, R. (1984). Predicting changes in perceived health status. American Journal of Public Health, 76(6), 611-613.
39. Gray, S. L., LaCroix, A. Z., Blough, D., Wagner, E. H., Koepsell, T. D., & Buchner, D. (2002). Is the use of benzodiazepines associated with incident disability? Journal of the American Geriatrics Society, 50, 1012-1018.
40. Grossberg, G. T., & Grossberg, J. A. (1998). Epidemiology of psychotherapeutic drug use in older adults. Clinics in Geriatric Medicine, 14(1), 1-5.
41. Grymonpre, R. E., Badger, M., Tabisz, E., Jacyk, W. R., & Powell, C. (1996). The development of a prescription drug dependence screen for older adults. Canadian Journal of Hospital Pharmacy, 49(1), 7-12.
42. Gustafsson, T. M., Isacson, D. G. L., Thorslund, M., & Sörbom, D. (1996). Factors associated with psychotropic drug use among the elderly living at home. Journal of Applied Gerontology, 15, 238-254.
43. Haack, M. R. (1998).Treating acute withdrawal from alcohol and other drugs. Nursing Clinics of North America, 33(1), 75-92.
44. Helman, C. G. (1981).Tonic, fuel and food: Social and symbolic aspects of long-term use of psychotropic drugs. Social Science and Medicine, 15B, 521-533.
45. Hohmann, A. A. (1989). Gender bias in prescribing in primary care. Medical Care, 27, 478-490.
46. Ilfeld, F. W. (1976). Further validation of a psychiatric symptom index in a normal population. Psychological Reports, 39, 1215-1228.
47. Ilfeld, F. W. (1978). Psychological status of community residents along major demographic dimensions. Archives of General Psychiatry, 35, 716-724.
48. Isacson, D. (1997). Long-term benzodiazepine use: Factors of importance and the development of individual use patterns over time: A 13-year follow-up in a Swedish community. Social Science and Medicine, 44, 1871-1880.
49. Jenkins, B. L. (1976). A case against "sleepers." Journal of Gerontological Nursing, 2(2), 10-13.
50. Jones, D. (1992). Characteristics of elderly people taking psychotropic medication. Drugs and Aging, 2, 389-394.
51. Jorm, A. F., Grayson, D., Creasey, H., Waite, L., & Broe, G. A. (2000). Long-term benzodiazepine use by elderly people living in the community. Australian and New Zealand Journal of Public Health, 24, 7-10.
52. Kelman, G., & Mayer-Oakes, S. A. (1994). Relationships between depression and the use of antidepressants and benzodiazepines in older community-dwelling Southern Californians. Clinical Gerontologist, 14(4), 71-72.
53. Kirby, M., Denihan, A., Bruce, I., Radic, A., Coakley, D., & Lawlor, B. A. (1999). Benzodiazepine use among the elderly in the community. International Journal of Geriatric Psychiatry, 14, 280-284.
54. Koenig, W., Rüther, E., & Filipiak, B. (1987). Psychotropic drug utilization patterns in a metropolitan population. European Journal of Clinical Pharmacology, 32, 43-51.
55. Kung, F., Gibson, S. J., & Helme, R. D. (1999). Factors associated with analgesic and psychotropic medication use by community-dwelling older people with chronic pain. Australian and New Zealand Journal of Public Health, 23, 471-474.
56. Lagnaoui, R., Bégaud, B., Moore, N., Chaslerie, A., Fourrier, A., Letenneur, L., et al. (2002). Benzodiazepine use and risk of dementia: A nested case-control study. Journal of Clinical Epidemiology, 55, 314-318.
57. Larose, D. (1996). Les habitudes de consommation de psychotropes chez les personnes âgées. Santé mentale au Québec, 21, 291-296.
58. Linden, M., Lecrubier, Y., Bellantuono, C., Benkert, O., Kisely, S., & Simon, G. (1999). The prescribing of psychotropic drugs by primary care physicians: An international collaborative study. Journal of Clinical Psychopharmacology, 19, 132-139.
59. Linjakumpu, T., Hartikainen, S., Klaukka, T., Koponen, H., Kivelä, S.-L., & Isoaho, R. (2002). Psychotropics among the home-dwelling elderly: Increasing trends. International Journal of Geriatric Psychiatry, 17, 874-883.
60. Lockwood, A., & Berbatis, C. G. (1990). Psychotropic drugs in Australia: Consumption patterns. Medical Journal of Australia, 153, 604-611.
61. Lyndon, R. W., & Russell, J. D. (1990). Can overuse of psychotropic drugs by the elderly be prevented? Australian and New Zealand Journal of Psychiatry, 24, 77-81.
62. Mamdani, M., Herrmann, N., & Austin, P. (1999). Prevalence of antidepressant use among older people: Population-based observations. Journal of the American Geriatrics Society, 47, 1350-1353.
63. Marinier, R. L., Pihl, R. O., Wilford, C., & Lapp, J. E. (1985). Psychotropic drug use by women: Demographic, lifestyle, and personality correlates. Drug Intelligence and Clinical Pharmacy, 19, 40-45.
64. Mayer-Oakes, S. A., Kelman, G., Beers, M. K., De Jong, F., Matthias, R., Atchison, A., Lubben, J. E., & Schweitzer, S. O. (1993). Benzodiazepine use in older, community-dwelling Southern Californians: Prevalence and clinical correlates. Annals of Pharmacotherapy, 27, 416-421.
65. McLeod, P. J., Hung, A. R., Tamblyn, A. R., & Gayton, D. C. (1997). Defining inappropriate practice in prescribing for elderly people: A national consensus panel. Canadian Medical Association Journal, 156, 385-391.
66. Miller, N. S., & Mahler, J. C. (1991). Addiction to and dependence on benzodiazepines. Diagnostic confusion in clinical practice and research studies. Journal of Substance Abuse Treatment, 8, 61-67.
67. Mort, J. R., & Aparasu, R. R. (2002). Prescribing of psychotropics in the elderly: Why is it so often inappropriate? CNS Drugs, 16, 99-109.
68. Mossey, J. M., & Shapiro, E. (1982). Self-rated health: A predictor of mortality among the elderly. American Journal of Public Health, 72, 800-808.
69. Newman, S. C., & Hassan, A. I. (1999). Antidepressant use in the elderly population in Canada: Results from a national survey. Journal of Gerontology: Medical Sciences, 54A, M527-M530.
70. Ohayon, M., Caulet, M., & Lemoine, P. (1996). Aging, sleep habits and psychotropic drug consumption in a general French population. Encephale, 22, 337-350.
71. Ohayon, M. M., Caulet, M., Priest, R. G., & Guilleminault, C. (1998). Psychotropic medication consumption patterns in the UK general population. Journal of Clinical Epidemiology, 51, 273-283.
72. Paterniti, S., Dufouil, C., & Alpérovitch, A. (2002). Long-term benzodiazepine use and cognitive decline in the elderly: The Epidemiology ofVascular Aging Study. Journal of Clinical Psychopharmacology, 22, 285-293.
73. Pérodeau, G., & Galbaud du Fort, G. (2000). Psychotropic drug use and the relation between social support, life events, and mental health in the elderly. Journal of Applied Gerontology, 19, 23-41.
74. Pérodeau, G., Jomphe-Hill, A., Hay-Paquin, L., & Amyot, E. (1996). Les psychotropes et le vieillissement normal: Une perspective psychosociale et socioéconomique. Revue canadienne du vieillissement, 15, 559-582.
75. Pérodeau, G., King, S., & Ostoj, M. (1992). Stress and psychotropic drug use among the elderly: An exploratory model. Canadian Journal of Aging, 11, 347-369.
76. Petrovic, M., Vandierendonck, A., Mariman, A., & Maele, G. V. (2002). Personality traits and socio-epidemiological status of hospitalized elderly benzodiazepine users. International Journal of Gerontological Psychiatry, 17, 733-738.
77. Pihl, R. O., Marinier, R., Lapp, J., & Drake, H. (1982). Psychotropic drug use by women: Characteristics of high consumers. International Journal of the Addictions, 17, 259-269.
78. Préville, M., Boyer, R., Potvin, L., Perreault, C., & Légaré, G. (1992). La démoralisation: Détermination de la validité et de la fiabilité de la mesure utilisée dans l'Enquête santé Québec. Cahier de recherche no. 7. Montreal: Enquête Santé Québec.
79. Préville, M., Hébert, R., Boyer, R., & Bravo, G. (2001). Correlates of psychotropic drug use in the elderly compared to adults aged 18-64: Results from the Quebec Health Survey. Aging and Mental Health, 5(3), 216-224.
80. Préville, M., Potvin, L., & Boyer, R. (1995). The structure of psychological distress in a population sample. Psychological Report, 77, 275-293.
81. Ray, W. A. (1992). Psychotropic drugs and injuries among the elderly: A review. Journal of Clinical Psychopharmacology, 12, 386-396.
82. Rickels, K., Schweizer, E., Case, G., & Greenblatt, D. J. (1990). Long-term therapeutic use of benzodiazepines. 1: Effects of abrupt discontinuation. Archives of General Psychiatry, 47, 899-907.
83. Ried, L. D., Johnson, R. E., & Gettman, D. A. (1998). Benzodiazepine exposure and functional status in older people. Journal of the American Geriatrics Society, 46, 71-77.
84. Sleath, B., Svarstad, B., & Roter, D. (1997). Physician vs. patient initiation of psychotropic prescribing in primary care setting: A content analysis of audio-tapes. Social Science and Medicine, 44, 541-548.
85. Spagnoli, A., Ostino, G., Borga, A. D., D'Ambrosio, R., Magiorotti, P., Todisco, E., et al. (1989). Drug compliance and unreported drugs in the elderly. Journal of the American Geriatrics Society, 37, 92-98.
86. Statistics Canada. 1994. Canada's Alcohol and Other Drugs Survey. Ottawa: Health Canada.
87. Stewart, R. B. (1994). Benzodiazepine use in an ambulatory elderly population: A 14-year overview. Clinical Therapeutics, 16, 118-124.
88. Straand, J., & Rockstad, K. (1997). General practitioners' prescribing patterns of benzodizepine hypnotics: Are elderly patients at particular risk for over-prescribing? Scandinavian Journal of Primary Health Care, 15, 16-21.
89. Tabloski, P. A., Cooke, K. M., & Thoman, E. B. (1998). A procedure for withdrawal of sleep medication in elderly women who have been long-term users.Journal of Gerontological Nursing, 24(9), 20-28.
90. Talerico, K. A. (2002). A critique of research measures used to assess inappropriate psychoactive drug use in older adults. Journal of the American Geriatrics Society, 50, 374-377.
91. Tamblyn, R. M., Laprise, R., Schnarch, B., Monette, J., & McLeod, P. J. (1996). Caractéristiques des médecins prescrivant des psychotropes davantage aux femmes qu'aux hommes. Santé mentale au Québec, 22, 239-262.
92. Tamblyn, R. M., McLeod, P. J., Abrahamowicz, M., Monette, J., Gayton, D. C., Berkson, L., et al. (1994). Questionable prescribing for elderly patients in Quebec. Canadian Medical Association Journal, 150, 1801-1809.
93. Taylor, S., McCracken, C. F. M., Wilson, K. C. M., & Copeland, J. R. M. (1998). Extent and appropriateness of benzodiazepine use. British Journal of Psychiatry, 173, 433-438.
94. Thomson, M., & Smith, W. A. (1995). Prescribing benzodiazepines for non-institutionalized elderly. Canadian Family Physician, 41, 792-798.
95. Tromp, A. M., Pluijm, S. M., Smit, J. H., Deeg, D. J., Bouter, L. M., & Lips, P. (2001). Fall-risk screening test: A prospective study on predictors for falls in community-dwelling elderly. Journal of Clinical Epidemiology, 54, 837-844.
96. Van der Waals, F. J., Mohrs, J., & Foets, M. (1993). Sex differences among recipients of benzodiazepines in Dutch general practice. British Medical Journal, 307, 363-366.
97. Voyer, P. (1999). Les pilules sont ma responsabilité. L'Infirmière Canadienne, 95(7), 37-42.
98. Voyer, P. (2001). L'association entre la santé mentale et la consommation de psychotropes chez des aînés vivant dans la communauté. Doctoral dissertation, Faculté des études supérieures, Université de Montréal.
99. Voyer, P., Lauzon, S., Collin, J., & McCubbin, M. (2003). The consumption of psychotropic drugs by the elderly: A review of empirical studies. Unpublished manuscript.
100. Voyer, P., & Martin, L. S. (2003). Improving geriatric mental health nursing care: Making a case for going beyond psychotropic medications. International Journal of Mental Health Nursing, 12(1), 11-21.
101. Voyer, P., Richard, L., & Dupont, L. (2001). Changer une habitude pour gagner en latitude. L'Infirmière Canadienne, 2(8), 11-15.
102. Wancata, J., Benda, N., Meise, U., & Müller, C. (1997). Psychotropic drug intake in residents newly admitted to nursing homes. Psychopharmacology, 134, 115-120.
103. Ware, J. E., (1986).The assessment of health status. In L. H. Aiken & D. Mechanic (Eds.), Applications of social science to clinical medicine and health policy (pp. 204-228). New Brunswick, NJ: Rutgers University Press.
104. Wilson, K. C. M., Copeland, J. R. M., Taylor, S., Donoghue, J., & McCracken, C. F. M. (1999). Natural history of pharmacotherapy of older depressed community residents:The MRC-ALPHA Study. British Journal of Psychiatry, 175, 439-443.
105. Zarifian, E. (1998). La prescription des médicaments psychotropes: Usage, mésusage et abus. The prescription of psychotropic drugs: Use, misuse and abuse. Bulletin de l'Academie Nationale de Médecine, 182, 1439-1447.